vTv Therapeutics (VTVT) Short-Term Debt issuances (2017)

vTv Therapeutics' (VTVT) quarterly Short-Term Debt issuances came in at $7.5 million in Q1 2017.

vTv Therapeutics (VTVT) Short-Term Debt issuances (2017) Analysis & Trends

vTv Therapeutics has disclosed Short-Term Debt issuances across 1 years of filings, most recently posting $7.5 million for Q1 2017.

Short-Term Debt issuances for Q1 2017 came in at $7.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $7.5 million (changed N/A YoY), and the FY2017 annual result was $7.5 million, down 40.0% from the prior year.
Short-Term Debt issuances came in at $7.5 million for Q1 2017 at vTv Therapeutics.
In the past five years, Short-Term Debt issuances ranged from a high of $7.5 million in Q1 2017 to a low of $7.5 million in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Short-Term Debt issuances (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-33,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	vTv Therapeutics	426.76 Mn	426.76 Mn	-	-

Download Data

Date	Value
Mar 31, 2017	7.50 Mn
Mar 31, 2017	7.50 Mn